Chaos and reliability in balanced spiking networks with temporal drive

Autor Lajoie, Guillaume, Lin, Kevin K., Shea-Brown, Eric
Vydáno 2013

Including probe-level uncertainty in model-based gene expression clustering

Autor Liu, Xuejun, Lin, Kevin K, Andersen, Bogi, Rattray, Magnus
Vydáno 2007

Phase-Amplitude Descriptions of Neural Oscillator Models

Autor Wedgwood, Kyle CA, Lin, Kevin K, Thul, Ruediger, Coombes, Stephen
Vydáno 2013

The influence of multiple firing events on the formation and stability of activity patterns in continuous attractor networks

Autor Lyttle, David, Weitzenfeld, Alfredo, Fellous, Jean-Marc, Lin, Kevin K
Vydáno 2013

Spatial scale and place field stability in a grid-to-place cell model of the dorsoventral axis of the hippocampus

Autor Lyttle, David, Gereke, Brian, Lin, Kevin K., Fellous, Jean-Marc
Vydáno 2013

The epidermal differentiation-associated Grainyhead gene Get1/Grhl3 also regulates urothelial differentiation

Autor Yu, Zhengquan, Mannik, Jaana, Soto, Amelia, Lin, Kevin K, Andersen, Bogi
Vydáno 2009

Estimating replicate time shifts using Gaussian process regression

Autor Liu, Qiang, Lin, Kevin K., Andersen, Bogi, Smyth, Padhraic, Ihler, Alexander
Vydáno 2010

Bayesian detection of non-sinusoidal periodic patterns in circadian expression data

Autor Chudova, Darya, Ihler, Alexander, Lin, Kevin K., Andersen, Bogi, Smyth, Padhraic
Vydáno 2009

Encoding in Balanced Networks: Revisiting Spike Patterns and Chaos in Stimulus-Driven Systems

Autor Lajoie, Guillaume, Lin, Kevin K., Thivierge, Jean-Philippe, Shea-Brown, Eric
Vydáno v PLoS Comput Biol (2016)

Identification of hair cycle-associated genes from time-course gene expression profile data by using replicate variance

Autor Lin, Kevin K., Chudova, Darya, Hatfield, G. Wesley, Smyth, Padhraic, Andersen, Bogi
Vydáno 2004

Circadian Clock Genes Contribute to the Regulation of Hair Follicle Cycling

Autor Lin, Kevin K., Kumar, Vivek, Geyfman, Mikhail, Chudova, Darya, Ihler, Alexander T., Smyth, Padhraic, Paus, Ralf, Takahashi, Joseph S., Andersen, Bogi
Vydáno 2009

Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility

Autor Quigley, David A, To, Minh D, Kim, Il Jin, Lin, Kevin K, Albertson, Donna G, Sjolund, Jonas, Pérez-Losada, Jesús, Balmain, Allan
Vydáno 2011

Co-factors of LIM domains (Clims/Ldb/Nli) regulate corneal homeostasis and maintenance of hair follicle stem cells

Autor Xu, Xiaoman, Mannik, Jaana, Kudryavtseva, Elena, Lin, Kevin K., Flanagan, Lisa A., Spencer, Joel, Soto, Amelia, Wang, Ning, Lu, Zhongxian, Yu, Zhengquan, Monuki, Edwin S., Andersen, Bogi
Vydáno 2007

A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance

Autor Hu, Hsien-Ming, Zhao, Xin, Kaushik, Swati, Robillard, Lilliane, Barthelet, Antoine, Lin, Kevin K., Shah, Khyati N., Simmons, Andy D., Raponi, Mitch, Harding, Thomas C., Bandyopadhyay, Sourav
Vydáno v Cell Rep (2018)

Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation

Autor Shroff, Rachna T., Hendifar, Andrew, McWilliams, Robert R., Geva, Ravit, Epelbaum, Ron, Rolfe, Lindsey, Goble, Sandra, Lin, Kevin K., Biankin, Andrew V., Giordano, Heidi, Vonderheide, Robert H., Domchek, Susan M.
Vydáno v JCO Precis Oncol (2018)

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Autor Kondrashova, Olga, Topp, Monique, Nesic, Ksenija, Lieschke, Elizabeth, Ho, Gwo-Yaw, Harrell, Maria I., Zapparoli, Giada V., Hadley, Alison, Holian, Robert, Boehm, Emma, Heong, Valerie, Sanij, Elaine, Pearson, Richard B., Krais, John J., Johnson, Neil, McNally, Orla, Ananda, Sumitra, Alsop, Kathryn, Hutt, Karla J., Kaufmann, Scott H., Lin, Kevin K., Harding, Thomas C., Traficante, Nadia, deFazio, Anna, McNeish, Iain A., Bowtell, David D., Swisher, Elizabeth M., Dobrovic, Alexander, Wakefield, Matthew J., Scott, Clare L.
Vydáno v Nat Commun (2018)

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Autor Coleman, Robert L, Oza, Amit M, Lorusso, Domenica, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I, Clamp, Andrew, Scambia, Giovanni, Leary, Alexandra, Holloway, Robert W, Gancedo, Margarita Amenedo, Fong, Peter C, Goh, Jeffrey C, O’Malley, David M, Armstrong, Deborah K, Garcia-Donas, Jesus, Swisher, Elizabeth M, Floquet, Anne, Konecny, Gottfried E, McNeish, Iain A, Scott, Clare L, Cameron, Terri, Maloney, Lara, Isaacson, Jeff, Goble, Sandra, Grace, Caroline, Harding, Thomas C, Raponi, Mitch, Sun, James, Lin, Kevin K, Giordano, Heidi, Ledermann, Jonathan A
Vydáno v Lancet (2017)

Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma

Autor Kondrashova, Olga, Nguyen, Minh, Shield-Artin, Kristy, Tinker, Anna V., Teng, Nelson N.H., Harrell, Maria I., Kuiper, Michael J., Ho, Gwo-Yaw, Barker, Holly, Jasin, Maria, Prakash, Rohit, Kass, Elizabeth M., Sullivan, Meghan R., Brunette, Gregory J., Bernstein, Kara A., Coleman, Robert L., Floquet, Anne, Friedlander, Michael, Kichenadasse, Ganessan, O'Malley, David M., Oza, Amit, Sun, James, Robillard, Liliane, Maloney, Lara, Giordano, Heidi, Wakefield, Matthew J., Kaufmann, Scott H., Simmons, Andrew D., Harding, Thomas C., Raponi, Mitch, McNeish, Iain A., Swisher, Elizabeth M., Lin, Kevin K., Scott, Clare L.
Vydáno v Cancer Discov (2017)

Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)

Autor Swisher, Elizabeth M., Kwan, Tanya T., Oza, Amit M., Tinker, Anna V., Ray-Coquard, Isabelle, Oaknin, Ana, Coleman, Robert L., Aghajanian, Carol, Konecny, Gottfried E., O’Malley, David M., Leary, Alexandra, Provencher, Diane, Welch, Stephen, Chen, Lee-may, Wahner Hendrickson, Andrea E., Ma, Ling, Ghatage, Prafull, Kristeleit, Rebecca S., Dorigo, Oliver, Musafer, Ashan, Kaufmann, Scott H., Elvin, Julia A., Lin, Douglas I., Chambers, Setsuko K., Dominy, Erin, Vo, Lan-Thanh, Goble, Sandra, Maloney, Lara, Giordano, Heidi, Harding, Thomas, Dobrovic, Alexander, Scott, Clare L., Lin, Kevin K., McNeish, Iain A.
Vydáno v Nat Commun (2021)

Characterization of a RAD51C-silenced high-grade serous ovarian cancer model during development of PARP inhibitor resistance

Autor Hurley, Rachel M, McGehee, Cordelia D, Nesic, Ksenija, Correia, Cristina, Weiskittel, Taylor M, Kelly, Rebecca L, Venkatachalam, Annapoorna, Hou, Xiaonan, Pathoulas, Nicholas M, Meng, X Wei, Kondrashova, Olga, Radke, Marc R, Schneider, Paula A, Flatten, Karen S, Peterson, Kevin L, Becker, Marc A, Wong, Ee Ming, Southey, Melissa S, Dobrovic, Alexander, Lin, Kevin K, Harding, Thomas C, McNeish, Iain, Ross, Christian A, Wagner, Jill M, Wakefield, Matthew J, Scott, Clare L, Haluska, Paul, Wahner Hendrickson, Andrea E, Karnitz, Larry M, Swisher, Elizabeth M, Li, Hu, Weroha, S John, Kaufmann, Scott H
Vydáno v NAR Cancer (2021)